Lifevantage (NASDAQ:LFVN) Stock Passes Above 200-Day Moving Average - Here's What Happened

Key Points

• Lifevantage (NASDAQ:LFVN) shares moved above their 200-day moving average on Thursday, trading as high as $6.31 and last changing hands at $6.25.
• Analyst sentiment remains cautious: two analysts rate the stock “Hold”, and the current consensus price target is $5.00, below the recent trading price.
• The company recently raised its quarterly dividend to $0.05 per share from $0.04, equivalent to a 3.2% yield; however, its latest earnings missed estimates on both EPS and revenue.

Shares of Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.71 and traded as high as $6.31. Lifevantage shares last traded at $6.25, with a volume of 125,559 shares trading hands.

Analysts Set New Price Targets

A number of research firms recently commented on LFVN. Weiss Ratings raised Lifevantage from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, May 26th. Lake Street Capital lowered shares of Lifevantage from a "buy" rating to a "hold" rating and set a $5.00 price target for the company. in a research report on Thursday, May 7th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, Lifevantage presently has an average rating of "Hold" and a consensus target price of $5.00.

Lifevantage Price Performance

The firm has a fifty day moving average of $6.68 and a 200 day moving average of $5.71. The stock has a market capitalization of $78.88 million, a price-to-earnings ratio of 13.89 and a beta of 0.73.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The company had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Research analysts predict that Lifevantage Corporation will post 0.6 EPS for the current year.

Lifevantage Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.05 per share. This is a positive change from Lifevantage's previous quarterly dividend of $0.04. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.20 annualized dividend and a dividend yield of 3.2%. Lifevantage's payout ratio is presently 44.44%.

Institutional Trading of Lifevantage

Hedge funds have recently added to or reduced their stakes in the company. DGS Capital Management LLC acquired a new stake in Lifevantage during the first quarter valued at $44,000. Hsbc Holdings PLC acquired a new position in shares of Lifevantage in the first quarter worth about $51,000. JPMorgan Chase & Co. boosted its stake in shares of Lifevantage by 870.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company's stock worth $66,000 after acquiring an additional 4,499 shares in the last quarter. Franklin Resources Inc. purchased a new stake in shares of Lifevantage during the 4th quarter worth about $74,000. Finally, Jain Global LLC purchased a new stake in shares of Lifevantage during the 4th quarter worth about $76,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.